A Novel Formulation of Epoprostenol with Antimicrobial Properties, Administered Under Ambient Conditions, for Treatment of Patients with Pulmonary Arterial Hypertension

被引：0
|
作者：
Witchey-Lakshmanan, L.
Palepu, N.
Teja, B. B.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2010年 / 181卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3364
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Epoprostenol (Veletri®, Caripul®): A Review of Its Use in Patients with Pulmonary Arterial Hypertension
    Sarah L. Greig
    Lesley J. Scott
    Greg L. Plosker
    American Journal of Cardiovascular Drugs, 2014, 14 : 463 - 470
  • [32] Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study
    Chin, Kelly M.
    Badesch, David B.
    Robbins, Ivan M.
    Tapson, Victor F.
    Palevsky, Harold I.
    Kim, Nick H.
    Kawut, Steven M.
    Frost, Adaani
    Benton, Wade W.
    Lemarie, Jean-Christophe
    Bodin, Frederic
    Rubin, Lewis J.
    McLaughlin, Vallerie
    AMERICAN HEART JOURNAL, 2014, 167 (02) : 218 - +
  • [33] Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment
    Hall, S. M.
    Davie, N.
    Klein, N.
    Haworth, S. G.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (04) : 851 - 860
  • [34] Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension
    Stiebellehner, L
    Petkov, V
    Vonbank, K
    Funk, G
    Schenk, P
    Ziesche, R
    Block, LH
    CHEST, 2003, 123 (04) : 1293 - 1295
  • [35] Treatment with epoprostenol of pulmonary arterial hypertension following mitral valve replacement for mitral stenosis
    Elliott, CG
    Palevsky, HI
    THORAX, 2004, 59 (06) : 536 - 537
  • [36] Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension
    Sitbon, Olivier
    Manes, Alessandra
    Jais, Xavier
    Pallazini, Massimiliano
    Humbert, Marc
    Presotto, Luis
    de Nillette, Louis
    Zaccardelli, Divid
    Davis, Gillian
    Jeff, Roger
    Simonneau, Gerald
    Galie, Naareno
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (01) : 1 - 5
  • [37] Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension
    Simonneau, Gerald
    Rubin, Lewis J.
    Galie, Nazzareno
    Barst, Robyn J.
    Fleming, Thomas R.
    Frost, Adaani
    Engel, Peter
    Kramer, Mordechai R.
    Serdarevic-Pehar, Marjana
    Layton, Gary R.
    Sitbon, Olivier
    Badesch, David B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (07): : 689 - 697
  • [38] Novel Strategies in the Treatment of Pulmonary Arterial Hypertension
    Madonna, Rosalinda
    Cocco, Nino
    CURRENT DRUG TARGETS, 2016, 17 (07) : 817 - 823
  • [39] Novel strategies for treatment of pulmonary arterial hypertension
    Jasinska-Stroschein, Magdalena
    Orszulak-Michalak, Daria
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2017, 71 : 577 - 588
  • [40] Epoprostenol infusion therapy changes angiographic findings of pulmonary arteries in patients with idiopathic pulmonary arterial hypertension
    Sakuma, Masahito
    Demachi, Jun
    Nawata, Jun
    Suzuki, Jun
    Takahashi, Tohru
    Matsubara, Hiromi
    Akagi, Satoshi
    Shirato, Kunio
    CIRCULATION JOURNAL, 2008, 72 (07) : 1147 - 1151
12345